Rathi, AnubhavJhanjee, AnuragBhatia, M S2016-02-182016-02-182013-04Rathi Anubhav, Jhanjee Anurag, Bhatia M S. A Study of the Prevalence, Socio-Demographic and Clinical Correlates of Metabolic Syndrome (M S) in Drug-naive Patients of Anxiety and Depressive Disorders.A Study of the Prevalence, Socio-Demographic and Clinical Correlates of Metabolic Syndrome (M S) in Drug-naive Patients of Anxiety and Depressive Disorders. Delhi Psychiatry journal. 2013 Apr; 16(1): 7-14.0971-9571http://imsear.searo.who.int/handle/123456789/173408Backgroud: The prevalence of Metabolic Syndrome (MS) and its components is reported to be higher in population with mental illness as compared to general population across al diagnostic categories. There is a paucity of studies on the baseline prevalence of MS and its these studes have produced mixed results. The present study was therefore carried out in patients attending the out-patient (OPD) psychiatry department. Aims and Objective:To find out and compare the prevalence and socio-demographic and clinical correlates of MS in drug native patients of anxiety and depressive disorders. Materials and Methods: Socio-demographic details, were collected and analyzed using appropriate statistical tools. Results and Conclusions: The overall prevalence of metabolic syndrome was 23.5% while it was 46.2% in the depressive group and 9.5% in the anxiety group. 50% of the sample fulfilled at least one criterion for MS. While age, all MS components predicted MS overall; HDL, waist circumference and BMI predicted MS in depressive patient and HDL and triglyceride abnormalities predicted MS in the anxiety group.enMetabolic syndromeprevalencecorrelatesdepressive disorderanxiety disorderA Study of the Prevalence, Socio-Demographic and Clinical Correlates of Metabolic Syndrome (M S) in Drug-naive Patients of Anxiety and Depressive Disorders.Article